Intima media thickness to measure the thickness of artery walls
Intima media thickness (IMT) is a valuable research tool that can be used as surrogate end points in clinical trails, says Professor Stefan Agewall.
Cardiovascular diseases
How save are antiangiogenic and anti-inflammatory drugs really?
Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving…
New biomarkers in acute cardiac care
Professor C Mueller adressed the issue of new biomarkers in acute cardiac care on the ESC on Monday, 1st September. Read his comment in the following.
New biomarkers allow improved diagnosis
The BACH (Biomarkers in Acute Congestive Heart Failure) trail, an international, multi-marker study, analysed the diagnostic and prognostic precision of new biomarkers in patients with dyspnea (Shortness of Breath).
Childhood obesity
Recent studies have shown that overweight and obesity during childhood and adolescence have a negative impact on the functioning of the internal walls of the arteries, paving the way to the development of an arteriosclerotic disease from an increasingly early age.
World's first robot-assisted vascular surgery for aneurysm
London, UK - A Hansen Sensei* robot has been used to perform vascular surgery on a 78-year-old patient for an aneurysm that would have been thought too high-risk for conventional surgery.
Heart Failure Congress
Among the many aims of the Heart Failure Association of the ESC is the establishment of networks for the HF management, education and research.
Article • Cardiology
Implantable cardiac monitors
Syncope (fainting) is a leading cause of hospital emergency visits. In almost 10% of patients, syncope has a cardiac cause; in 50%, a non-cardiac cause, and in 40% the cause of syncope is unknown. Syncope is difficult to diagnose as syncopal episodes are often too infrequent and unpredictable for detection with conventional monitoring techniques.
Website advice for HF patients
A new educational website specifically for heart failure patients, their families and carers, has been set up by the Heart Failure Association of the European Society of Cardiology.
Atrial fibrillation
Seeking to set the agenda for urgent atrial fibrillation (AF) research, European and international cardiologists will gather this October at the European Heart House, in Sophia Antipolis, the headquarters of the European Society of Cardiology.
Early diagnosis
Under the banner Hear today the heartbeats of tomorrow, at this year's ESC meeting GE Healthcare will showcase its latest cardiology technology for the management of cardiovascular disease (CVD) as well as several new products.
SYNCOPE Diagnosis and therapy
The diagnostic work-up of syncope patients often raises the question of how much diagnosis is necessary and what examination methods are really needed. To save time, specialists recommend focusing on determining whether the syncope may be caused by a cardiac problem - a question answered quite easily in many cases. Karl Eberius MD, European Hospital's new correspondent, discussed advice for…
HeartVue 6S seeks USA marketing
Pegasus/Heartview LLC has announced that clinical studies of its HeartVue 6S Heart Screening System - which obtained CE Mark Approval in Europe almost two years ago - have been completed according to FDA guidelines, as a pre-marketing condition for release in the USA.
Economic recession: a cause of later CVD?
Bad economic conditions, e.g. a recession, at the time of birth may lead to a higher risk of cardiovascular mortality much later in life, according to a recent study published by researchers at the Institute for the Study of Labour (IZA) in Bonn.
Beijing Olympics research finds enlarged hearts can be good hearts
Cardiologist Dr Malissa Wood, of the Massachusetts General Hospital, Boston, USA, has reported that a study of Olympic athletes, using GE Healthcare's Vivid I cardiac compact ultrasound technology, has allowed the medical research team in Beijing to identify healthy patterns of heart enlargement that can differentiate it from hypertrophic cardiomyopathy.
CVD specialists meet footballers
The world's first symposium on the molecular analysis of sudden death syndrome (SDS) among athletes drew in leading cardiovascular researchers and several top Spanish footballers. Sponsored by Applied Biosystems, and held in the Madrid's Hospital Clinico San Carolos, the I Symposium de Prevención en el Futbol aims to initiate the development of new tests to identify sports players at SDS risk.
Article • Stroke prevention
Ultrasound brings many advantages, but trained sonographers are too few
What is the role of vascular ultrasound in stroke prevention? Asked by Karoline Laarmann of European Hospital, Professor Christian Arning MD, Medical Director of the Neurology Department at Asklepios Klinik Wandsbek, Germany, and Deputy Chairman of the German Society of Ultrasound in Medicine (DEGUM), gave an unequivocal answer: crucial - but only if the sonographer is properly qualified.
HIFU surgical ablation products gain CE Mark
St. Jude Medical, Inc. has received European CE Mark approval and US Food and Drug Administration (FDA) clearance for its Epicor LP cardiac ablation system, a second generation technology that uses HIFU (high intensity focused ultrasound) for surgical ablation of cardiac tissue to disrupt abnormal cardiac electrical impulses.
Atrial and ventricular contraction is differentially regulated
The contraction of the atria and ventricles is differentially regulated, according to a study by Rodolphe Fischmeister and colleagues, at INSERM UMR-S 769 in Châtenay-Malabry.
Heart failure
The ageing population and growing risk factors have made a significant impact on driving up the number of registered heart failure (HF) cases. Existing pharmacological strategies are improving the survival rates of acute and early-stage HF patients, ironically providing a growing body of patients with progression of the disease to HF.
EuroPRevent 2009
This year sees the fifth anniversary of EuroPRevent.
New Molecular Imaging Techniques Aim at Detection of Earliest Steps of Disease Development
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
Hypertension worldwide
Countries vary widely in their capacity to manage hypertension, but globally the majority of diagnosed hypertensives is inadequately controlled. Not treated it can cause cardiovascular disease (CVD), myocardial infarction and stroke. According to the WHO, hypertension is estimated to cause 4.5% of the current global disease burden and is as prevalent in many developing countries as in the…
euHeart
Royal Philips Electronics is to lead `euHeart´, the new European Union (EU) funded research project that aims to improve CVD diagnosis, therapy planning and treatment.
Hot topic cardiovascular imaging
Every summer the European Society of Cardiology (ESC) holds Europe's biggest annual meeting of specialists in cardiovascular medicine, inviting and drawing in top international medical professionals. Karoline Laarmann asked Professor Kim Fox, President of the European Society of Cardiology and Consultant Cardiologist at the Royal Brompton Hospital, and professor of clinical cardiology at Imperial…
